Results 261 to 270 of about 5,727,235 (316)
Reversal of Cerebral Glucose Hypometabolism in a Patient with COVID and Refractory B-Cell Lymphoma. [PDF]
Int Med Case Rep JDecosma L, Wolf E, Parent EE, Tun HW.
europepmc +1 more source
Infections after bispecific antibodies in B-cell lymphomas. [PDF]
Blood AdvKim DH +9 more
europepmc +1 more source
Lymph node microenvironment remodeling unlocks local antibody-mediated B cell depletion. [PDF]
Sci AdvGarcia Z +11 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Critical Care Medicine, 2005
B cells are an important component of adaptive immunity. They produce and secrete millions of different antibody molecules, each of which recognizes a different (foreign) antigen. The fact that humans express a very large repertoire of antibodies is due to the complex mechanism of V(D)J recombination of immunoglobulin (Ig) genes as well as other ...
Malcolm, MacConmara, James A, Lederer
openaire +4 more sources
B cells are an important component of adaptive immunity. They produce and secrete millions of different antibody molecules, each of which recognizes a different (foreign) antigen. The fact that humans express a very large repertoire of antibodies is due to the complex mechanism of V(D)J recombination of immunoglobulin (Ig) genes as well as other ...
Malcolm, MacConmara, James A, Lederer
openaire +4 more sources
Science, 2000
The transcription factor PU.1 is essential in B cell and macrophage development and proliferation. DeKoter and Singh show that the level of expression of PU.1 can control which cell fate will result. At low levels, PU.1 protein caused precursor cells to differentiate into B lymphocytes; whereas at high levels of PU.1, the same cells differentiated into
+4 more sources
The transcription factor PU.1 is essential in B cell and macrophage development and proliferation. DeKoter and Singh show that the level of expression of PU.1 can control which cell fate will result. At low levels, PU.1 protein caused precursor cells to differentiate into B lymphocytes; whereas at high levels of PU.1, the same cells differentiated into
+4 more sources
CD5 B cells and B-cell malignancies
Current Opinion in Hematology, 1999Over the past year, progress has been made in understanding of the physiology and disease associations of CD5+ (B1) B cells, although their exact role in pathogenesis remains unclear. Earlier studies on the negative function of CD5 within the B-cell receptor complex have been substantiated, and it seems likely that soon the signaling pathways used by ...
P M, Lydyard +3 more
openaire +2 more sources